Saslow L, Li DKB, Halper J, Banwell B, Barkhof F, Barlow L, Costello K, Damiri P, Dunn J, Giri S, Maes M, Morrow SA, Newsome SD, Oh J, Paul F, Quarterman P, Reich DS, Shewchuk JR, Shinohara RT, Van Hecke W, van de Ven K, Wallin MT, Wolinsky JS, Traboulsee A. An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies. Int J MS Care. Sep-Oct 2020;22(5):226-232.
Ackermans N, Taylor C, Tam R, Carruthers RC, Kolind S, Kang H, Li DKB, Traboulsee AL. Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Mult Scler J Exp Transl Clin. 2019 Feb 16;5(1):2055217318823796
Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019 Mar 12;92(11):519-533.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2.
Traboulsee A and Li D. Addressing concerns regarding the use of gadolinium in a standardized MRI protocol for the diagnosis and follow-up of multiple sclerosis. AJNR AM J Neuroradiol. 2016 Dec;37(12):E82-E83.
Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhota A, Newsome SD, Oh J, Reich DS, Richert N, Rammohan K, Khan O, Radue EW, Ford C, Halper J, Li D. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR AM J Neuroradiol. 2016 Mar;37(3):394-401.
Traboulsee A, Létourneau-Guillon L, Freedman MS, O’Connor PW, Bharatha A, Chakraborty S, Girard JM, Giuliani F, Lysack JT, Marriott JJ, Metz LM, Morrow SA, Oh J, Sharma M, Vandorpe RA, Vertinsky TA, Wadhwa VS, von Riedemann S, Li DK. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring. Can J Neurol Sci. 2015 May;42(3):159-67.
Arnold DL, Li D, Hohol M, Chakraborty S, Chankowsky J, Alikhani K, Duquette P, Bhan V, Montanera W, Rabinovitch H, Morrish W, Vandrope R, Guilbert F, Traboulsee A, Kremenchutzky M. Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian consensus recommendations. MSJ Exp. Transl. Clin. 1:2055217315589775
Traboulsee A, Li DK. Conventional MR imaging. Neuroimaging Clin N Am. 2008 Nov;18(4):651-73, x.
Li DK, Li MJ, Traboulsee A, Zhao G, Riddehough A, Paty D. The use of MRI as an outcome measure in clinical trials. Adv Neurol. 2006;98:203-26.
Traboulsee AL, Li DK. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol. 2006;98:125-46.
Traboulsee A, Zhao G, Li DK. Neuroimaging in multiple sclerosis. Neurol Clin. 2005 Feb;23(1):131-48, vii.